Lv5
900 积分 2025-06-05 加入
Targeting key epigenetic regulators in solid tumors: focus on EZH2, PRMT5, and BET inhibitors
13天前
已完结
Chromatin remodellers as therapeutic targets
19天前
已完结
Preclinical pharmacokinetics and metabolism of MAK683, a clinical stage selective oral embryonic ectoderm development (EED) inhibitor for cancer treatment
2个月前
已完结
Recent update on the development of EZH2 inhibitors and degraders for cancer therapy
2个月前
已完结
MK-0457, an Aurora kinase and BCR–ABL inhibitor, is active in patients with BCR–ABL T315I leukemia
6个月前
已完结
Free energy perturbation in the design of EED ligands as inhibitors of polycomb repressive complex 2 (PRC2) methyltransferase
9个月前
已完结
Recent Progress in DNA Damage Response-Targeting PROTAC Degraders
10个月前
已完结
Design and Application of Cereblon-Recruiting Prodegraders
10个月前
已完结
皖公网安备34019202002308
